Rohto Pharmaceutical Co Ltd
TSE:4527
Rohto Pharmaceutical Co Ltd
Cash from Financing Activities
Rohto Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Cash from Financing Activities
-¥13.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-23%
|
|
Shiseido Co Ltd
TSE:4911
|
Cash from Financing Activities
-¥75.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-8%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Cash from Financing Activities
-¥12.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-16%
|
|
Kao Corp
TSE:4452
|
Cash from Financing Activities
-¥80B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-2%
|
|
F
|
Fancl Corp
TSE:4921
|
Cash from Financing Activities
-¥4.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Cash from Financing Activities
-¥19.5B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-18%
|
See Also
What is Rohto Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-13.3B
JPY
Based on the financial report for Dec 31, 2023, Rohto Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -13.3B JPY.
What is Rohto Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-23%
Over the last year, the Cash from Financing Activities growth was -275%.